KINNOV THERAPEUTICS
🇫🇷France
Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:3
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (75.0%)Phase 2
1 (25.0%)A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine
Phase 1
Completed
- Conditions
- Alcohol Use Disorder
- Interventions
- First Posted Date
- 2023-11-27
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Kinnov Therapeutics
- Target Recruit Count
- 12
- Registration Number
- NCT06147622
- Locations
- 🇫🇷
Eurofins Optimed, Gières, France
Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects
- First Posted Date
- 2019-09-27
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- Kinnov Therapeutics
- Target Recruit Count
- 154
- Registration Number
- NCT04108104
- Locations
- 🇫🇷
Centre Hospitalier d'Abbeville, Abbeville, France
🇫🇷Centre d'Addictologie "Pierre-Fouquet" - CHD La Candélie, Agen, France
🇫🇷clinique de la Bréhonnière, Astillé, France
News
No news found